| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/18/2007 | WO2007008045A1 Pharmaceutical compositions containing clopidogrel bisulfate |
| 01/18/2007 | WO2007007971A1 Pharmaceutical compositions comprising sibutramine |
| 01/18/2007 | WO2007007894A1 Eye drop preparation comprising xanthan gum and terpenoid |
| 01/18/2007 | WO2007007832A1 Preservative composition for ophthalmic use |
| 01/18/2007 | WO2007007656A1 Pharmaceutical composition containing thiazolidinedione compound |
| 01/18/2007 | WO2007007021A1 Gentisic acid for stabilisig 123-i radiopharmaceuticals |
| 01/18/2007 | WO2007006484A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 01/18/2007 | WO2007006232A1 Hyaluronic acid phospholipid complex and preparing method thereof |
| 01/18/2007 | WO2006127121A3 Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use |
| 01/18/2007 | WO2006118952A3 Multi-component vitamin and mineral supplement for the optimal absorption of components |
| 01/18/2007 | WO2006110157A3 Nucleoside phosphonate conjugates as anti hiv agents |
| 01/18/2007 | WO2006109086A3 Method to predict the sensitivity of tumors to eg5 inhibitors |
| 01/18/2007 | WO2006099279A3 Elastomeric fising lure body |
| 01/18/2007 | WO2006078282A3 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 01/18/2007 | WO2006073748A3 Antibodies against antigen presenting cells and uses thereof |
| 01/18/2007 | WO2006024953A3 Glycerol branched polyethylene glycol human growth hormone conjugates, process for their preparation, and methods of use thereof |
| 01/18/2007 | WO2005084307A3 Use of lipid conjugates in the treatment of disease |
| 01/18/2007 | WO2005042695A3 Lipoparticles comprising proteins, methods of making, and using the same |
| 01/18/2007 | WO2005015160A3 Functionalized polymeric colloids |
| 01/18/2007 | WO2004071468A3 Short immunomodulatory oligonucleotides |
| 01/18/2007 | WO2004016762A3 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer |
| 01/18/2007 | WO2003020200A8 A novel pharmaceutical compound and methods of making and using same |
| 01/18/2007 | US20070015800 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
| 01/18/2007 | US20070015736 Filling plastic container with bisphosphonate solution; heat sterilization |
| 01/18/2007 | US20070015716 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 01/18/2007 | US20070015714 Methods for treating FSH related conditions with GnRH antagonists |
| 01/18/2007 | US20070015685 Bone cement compositions and the like comprising an RNAIII-inhibiting peptide |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070014876 Synergistic compositions and method for potentiating anti-oxidative activity |
| 01/18/2007 | US20070014875 Novel drug delivery system for proton pump inhibitors and process thereof |
| 01/18/2007 | US20070014863 Method of controlling paticle size of retinoic acid nanoparticles coated with polyvalent metal inorganic salt and nanoparticles obtained by the controlling method |
| 01/18/2007 | US20070014861 Treatment of proctitis |
| 01/18/2007 | US20070014860 Treatment of esophagitis |
| 01/18/2007 | US20070014857 Pharmaceutical formulation having a masked taste and method for the production thereof |
| 01/18/2007 | US20070014832 Therapeutic compositions and methods |
| 01/18/2007 | US20070014831 Biodegradable occlusive device with moisture memory |
| 01/18/2007 | US20070014818 Liquid formulations with high concentration of human growth hormone (HGH) comprising 1,2-propylene glycol |
| 01/18/2007 | US20070014812 Carrier proteins for vaccines |
| 01/18/2007 | US20070014756 Composition and method for treating the gastro-intestinal tract |
| 01/18/2007 | US20070014743 Subunguicide, and method for treating onychomycosis |
| 01/18/2007 | US20070014742 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash; drug delivery gum patch |
| 01/18/2007 | US20070014738 Particles for inhalation having sustained release properties |
| 01/18/2007 | US20070014737 Administering quinine, chlorzoxazone, cyclobenzaprine, carisoprodol via vaporization |
| 01/18/2007 | US20070014735 Buccal delivery system |
| 01/18/2007 | US20070014725 Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy |
| 01/18/2007 | DE3915617B4 Verwendung einer ein Cyclosporin enthaltenden Zusammensetzung zur topischen Applikation Use of a composition containing a cyclosporin for topical application |
| 01/18/2007 | DE102005033347A1 Mittel, enthaltend mindestens ein Alkalimetallhalogenid als Tracer Means containing at least an alkali metal halide as a tracer |
| 01/18/2007 | DE102005032806A1 Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten Use of a partially neutralized anionic (meth) acrylate copolymer as a coating for the manufacture of a dosage form with an active ingredient release at reduced pH values |
| 01/18/2007 | CA2615319A1 Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof |
| 01/18/2007 | CA2615108A1 Preservative composition for ophthalmic use |
| 01/18/2007 | CA2615053A1 Pharmaceutical formulations of endo-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride |
| 01/18/2007 | CA2614619A1 Formulations for enhanced mucosal delivery of pyy |
| 01/18/2007 | CA2614200A1 Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds |
| 01/18/2007 | CA2613976A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 01/18/2007 | CA2613619A1 Sp1 polypeptides, modified sp1 polypeptides and uses thereof |
| 01/17/2007 | EP1743907A1 Conjugate of cyclodextrin and poly(oxyethylene), and process for preparation thereof |
| 01/17/2007 | EP1743657A2 Stabilisation of macrolides |
| 01/17/2007 | EP1743646A2 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 01/17/2007 | EP1743645A1 Adhesive patch |
| 01/17/2007 | EP1743629A1 Process for preparing oral calcium compositions |
| 01/17/2007 | EP1743041A1 Modified viral vector particles |
| 01/17/2007 | EP1742985A1 Perfluoropolyether containing acrylat groups |
| 01/17/2007 | EP1742966A2 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 01/17/2007 | EP1742707A2 Treatment of cns disorders using cns target modulators |
| 01/17/2007 | EP1742667A1 Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same |
| 01/17/2007 | EP1742666A2 Preservative system |
| 01/17/2007 | EP1742665A1 Delivery system for bioactive agents on the basis of a polymeric drug carrier comprising an amphiphilic block polymer and a polylacticacid derivative |
| 01/17/2007 | EP1742664A1 Permeation enhancing compositions for anticholinergic agents |
| 01/17/2007 | EP1742663A2 Compositions capable of facilitating penetration across a biological barrier |
| 01/17/2007 | EP1742642A2 Phosphonate analogs of hiv integrase inhibitor compounds |
| 01/17/2007 | EP1742638A1 Composition comprising a diuretic and/or cardiac glycoside for the treatment of dna viral infections of the eye |
| 01/17/2007 | EP1742620A1 Method of making silicone pressure sensitive adhesives for delivering hydrophilic drugs using a silicone polyether |
| 01/17/2007 | EP1742617A2 Lozenge for delivery of dextromethorphan |
| 01/17/2007 | EP1742609A1 Dermally applicable liquid formulations for controlling parasitic arthropods on animals |
| 01/17/2007 | EP1742604A1 Skin care and cleansing compositions containing oil seed product |
| 01/17/2007 | EP1742530A2 Antimicrobial coating for inhibition of bacterial adhesion and biofilm formation |
| 01/17/2007 | EP1643990B1 Metronidazole-based green tinted topical pharmaceutical composition |
| 01/17/2007 | EP1450762B1 Novel formulation |
| 01/17/2007 | EP1441667B1 Improved endoprosthetic device |
| 01/17/2007 | EP1337233B1 Use of at least a sulphonic amino derivative in a composition promoting skin peeling |
| 01/17/2007 | EP1322411B1 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1272160B1 Lipid-based drug delivery systems for topical application |
| 01/17/2007 | EP1244388B1 Intervertebral disc treatment device |
| 01/17/2007 | EP1224188B1 Nasal delivery composition comprising the methane sulphonate salt of morphine and chitosan |
| 01/17/2007 | EP1084170B1 Polyethylene glycol-polyorthoester, polyethylene glycol-polyorthoester-polyethylene glycol, and polyorthoester-polyethylene glycol-polyorthoester block copolymers |
| 01/17/2007 | CN1898378A Stem cell targeting using magnetic particles |
| 01/17/2007 | CN1897979A Gas-filled microvesicle assembly for contrast imaging |
| 01/17/2007 | CN1897978A Assembly of gas-filled microvesicle with active component for contrast imaging |
| 01/17/2007 | CN1897976A Antagonists of the bradykinin b1 receptor |
| 01/17/2007 | CN1897975A Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof |
| 01/17/2007 | CN1897974A Medicinal lipolysis of accumulations of fat |
| 01/17/2007 | CN1897970A Specific human antibodies |
| 01/17/2007 | CN1897967A A pharmaceutical composition comprising an active principle and sulphobetaine |
| 01/17/2007 | CN1897942A Pharmaceutical compositions |
| 01/17/2007 | CN1897940A Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| 01/17/2007 | CN1897929A Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid |
| 01/17/2007 | CN1897926A Pharmaceutical formulations of bisphosphonates |
| 01/17/2007 | CN1897923A 控释药物制剂 Controlled release pharmaceutical preparation |
| 01/17/2007 | CN1897921A Consumer customized dosage forms |